Hepatitis Monthly
Official Journal of Research Center for Gastroenterology and Liver Diseases
The effect of desacetyluvaricin on the expression of TLR4 and P53 protein in Hepg 2.2.15
# These authors have contributed equally.
Abstract
Background: Previous studies suggest that annonaceous may cause permeability glycoprotein (P-gp) function to abate, leading to cell apoptosis. It has also been reported that annonaceous acetogenins affect hepatocellular carcinoma (HCC) cells in the G1 phase, leading to apoptosis. Desacetyluvaricin (Des), a new type of annonaceous acetogenin monomer, has a significant effect on HCC, with few side effects.
Objectives: To investigate the effect of Des on the expression of Toll-like receptor 4 (TLR4) and P53 protein in HCC.
Materials and Methods: HCC HepG2.2.15 cell was cultured by routine method. HepG2.2.15 cells were divided into three groups: control group, treated with Des and DDP (cisplatin) which were examined by immunofluorescence flow cytometry for expression of TLR4 and P53.
Results: TLR4 was expressed by more cells in the Des group than in the cisplatin or serum-only groups (71.94%, 42.64%, and 37.16%, respectively; Des vs.cisplatin: p < 0.05; Des vs. serum only: p < 0.05), with no difference between the cisplatin and serum-only groups (p > 0.05). P53 was expressed by more cells in the Des and cisplatin groups than in the serum-only group (32.6%, 31.5% and 3.3%, respectively; Des vs. serum only, p < 0.05; cisplatin vs. serum only, p < 0.05), with no difference between the Des and cisplatin groups (p > 0.05).
Conclusions: Des increases TLR4 and P53 expression in HCC cells. Improved immune recognition by the former effect and induction of apoptosis by the latter could be the mechanisms of Des's clinical effects on HCC.
Keywords: Desacetyluvaricin; TLR4 receptor; P53 tumor suppressor protein; Flow cytometry; Hepatocellular carcinoma
2011 Kowsar M.P.Co. All rights reserved.
Copyright
© 2011, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Similar Articles
Potential Anti-Tumor Activity of Kefir-Induced Juglone and Resveratrol Fractions Against Ehrlich Ascites Carcinoma-Bearing BALB/C Mice
Bozkurt E, Atay E, Pektaş G, Ertekin A, Vurmaz A, et al. Potential Anti-Tumor Activity of Kefir-Induced Juglone and Resveratrol Fractions Against Ehrlich Ascites Carcinoma-Bearing BALB/C Mice. Iran J Pharm Res. 2020;19(3):e124616. doi: https://doi.org/10.22037/ijpr.2020.112993.14060
MicroRNA-642a-5p Targets DNA Damage-Inducible Transcript 4 to Suppress Hepatitis B Virus Hepatoma Carcinoma Cell
Ding M, Yang J, Zeng X, Liu P, Zhang S, et al. MicroRNA-642a-5p Targets DNA Damage-Inducible Transcript 4 to Suppress Hepatitis B Virus Hepatoma Carcinoma Cell. Jundishapur J Microbiol. 2024;17(3):e145798. doi: https://doi.org/10.5812/jjm-145798
Stem Cell-Derived Exosomes Significantly Boost Etoposide-Induced Apoptosis in HepG2 Liver Cancer Cells: A Novel Strategy for Enhanced Chemotherapy
Naeeni B, Jaberian Asl B, Salehipour Bavarsad S, Hatami M, Orak G, et al. Stem Cell-Derived Exosomes Significantly Boost Etoposide-Induced Apoptosis in HepG2 Liver Cancer Cells: A Novel Strategy for Enhanced Chemotherapy. Hepat Mon. 2025;25(1):e162001. doi: https://doi.org/10.5812/hepatmon-162001
Dicer Inhibits Hepatocellular Carcinoma by Inhibiting the Interleukin 6 Pathway
Ma H, Xing N, Hou L, Wu J, Sha Z, et al. Dicer Inhibits Hepatocellular Carcinoma by Inhibiting the Interleukin 6 Pathway. Hepat Mon. 2023;23(1):e134381. doi: https://doi.org/10.5812/hepatmon-134381
Inhibition of Inflammatory Signals “HMGB1, NLRP3, TNF-α, IL-1β” and Oxidative Stress in Diclofenac-Induced Hepatotoxicity in Rats Using Hydroalcoholic Extract of Dracocephalum kotschyi
Karimi-Dehkordi M, Saghaei F, Hoseini E. Inhibition of Inflammatory Signals “HMGB1, NLRP3, TNF-α, IL-1β” and Oxidative Stress in Diclofenac-Induced Hepatotoxicity in Rats Using Hydroalcoholic Extract of Dracocephalum kotschyi. Iran J Pharm Res. 2025;24(1):e162656. doi: https://doi.org/10.5812/ijpr-162656
- Scopus by DOI: 0
Last Update: 2 weeks ago
- Scopus by Title: 11
Last Update: 2 weeks ago
- Scopus by Title (Ref): 11
Last Update: 2 weeks ago
- CrossRef: 0
Last Update: 6 days ago
Ordering Reprints
Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC
Author(s):